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Highlights 
 The colonization rate of MRSE (91%) was unusually high among hospital personnel 
from two hospitals in Tianjin, China, who were carriers of S. epidermidis. 
 The MRSE isolates had high resistance rates towards β-lactam antibiotics, but low 
resistance rates against non-β-lactam antibiotics. 
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 The majority of MRSE in this study belonged to cluster II domain of CC2. ST59-
IV was the predominant clone among isolates recovered from hospital personnel, a 
sequence type that was reportedly associated with clinical infections. 
 New MLST types were determined, thus confirming the genetic diversity of these 
isolates. 
 The hospital personnel may well act as a reservoir of antimicrobial resistant 
pathogens. 
 
Abstract 
Objectives 
Staphylococcus epidermidis is a major nosocomial pathogen predominantly associated with indwelling 
medical device infections. Studies reporting on S. epidermidis recovered from hospital personnel in 
China are scarce. The aim of this study was to evaluate the carriage and antibiotic resistance of S. 
epidermidis among the hospital personnel in Tianjin, China and provide insights into their genetic 
diversity.   
Methods 
107 S. epidermidis isolates were recovered from 68 hospital personnel in two public hospitals in Tianjin 
between March 2018 and May 2018. SCCmec types were determined by the combination of mec and ccr 
complexes. Multi-locus sequence typing was used to determine the sequence types (ST) of S. epidermidis 
isolates. 
Results 
62 (76.5%) isolates were determined to be methicillin-resistant S. epidermidis (MRSE). 35 (51%) out of 
68 hospital personnel carried S. epidermidis, of which 32 (91%) were carriers of MRSE. All 62 MRSE 
isolates had high levels of resistance to penicillin (90%) and cefoxitin (100%). 37 (60%) isolates carried 
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SCCmec type IV, followed by 15 (24%) carrying SCCmec V, and 4 (6%) SCCmec II. Novel sequence 
types were assigned to four S. epidermidis isolates (ST832, ST833, ST834 and ST835).  
Conclusions 
In this study, the majority of MRSE belonged to cluster II domain of CC2. The ST59-IV was a dominant 
clone among isolates recovered from hospital personnel. Determination of new MLST types confirmed 
the genetic diversity of these isolates. These observations highlight the need to review the infection 
control strategies to reduce the carriage of MRSE among hospital personnel. 
 
Keywords: Staphylococcus epidermidis, hospital personnel, mecA, SCCmec, MLST, sequence type 
 
1. Introduction 
Staphylococcus epidermidis is a common colonizer of the human skin [1], but also one of the major 
opportunistic pathogens responsible for medical device associated infections (MDAI). However, the role 
of S. epidermidis as a nosocomial pathogen has been underestimated until late 1980s [2]. Recently, 
several studies reported that the distribution of S. epidermidis in human clinical samples was higher than 
infections caused by S. aureus in Greece and India [1,3]. The ever increasing antibiotic resistance 
aggravates the problem, and poses a greater challenge for the control of hospital acquired infections [4].  
Methicillin resistance is mediated by the mecA gene, which encodes penicillin binding protein 2a that 
has low affinity to β-lactam antibiotics, and thus confers methicillin resistance [5]. The mecA gene is 
located on a mobile genetic island named staphylococcal cassette chromosome mec (SCCmec). Up to 
date eleven SCCmec types have been assigned based on combinations of mec and ccr complexes [6]. 
Molecular typing methods, including multi-locus sequence typing have been instrumental to identify 
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highly diverse genetic lineages of S. epidermidis [7].  S. epidermidis species have been assigned onto 
one major clonal complex (CC2), 8 minor clonal complexes and 13 singletons [8]. 
While there are many studies reporting the molecular epidemiology of S. aureus, studies reporting the 
molecular characteristics of S. epidermidis are fragmentary. It has been documented that hospital 
personnel  are often carriers of methicillin-resistant staphylococci and aid the dissemination of hospital 
–acquired infections [9]. However, little is known about the genotypic diversity of methicillin-resistant 
S. epidermidis (MRSE) among hospital personnel in China. To our knowledge, only two studies have 
reported acquisition of MRSE among hospital personnel with 89% of hospital personnel carrying MRSE 
in Sweden [10] and 30% in Shanghai, China [11].   
In this study, we evaluate the carriage and susceptibility patterns of MRSE among the hospital personnel 
recovered from two hospitals in Tianjin, China and provide insights into their genetic diversity.   
2. Material and Methods 
2.1 Study protocol 
As a part of a small surveillance study to assess the carriage of MRSE among the hospital personnel, one 
hundred and seven samples were recovered from the hospital personnel (n=68) in two public hospitals in 
Tianjin city, North China, between March 2018 and May 2018. Samples were taken from doctors and 
nurses’ hands (n=68) and nasal cavity (n=39).  
The research protocol and informed consent was approved by the Ethics committee of Tianjin Science 
and Technology Commission (approval No TMUaMEC2017017). All research was performed in 
accordance with the relevant guidelines and regulations. Informed consent was obtained from all 
participants. 
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All specimens were inoculated onto mannitol salt agar (MSA, Oxoid, Basingstoke, UK) and incubated 
aerobically at 37 ℃ for 24-48 h.  
2.2 Identification 
S. epidermidis isolates were subjected to partial 16S rRNA gene sequencing using the primers and PCR 
conditions as described previously [12]. Amplified PCR products were sequenced by Sangon Biotech 
(Shanghai, China). Homology searches were carried out using BLAST tool (NCBI: 
https://www.ncbi.nlm.nih.gov/ ) [13]. 
2.3 Antimicrobial susceptibility test 
Susceptibility to ten antibiotics was tested for all isolates using standard disk diffusion method. The 
antibiotics tested included: CN: gentamicin (10 µg), E: erythromycin (15 µg), FOX: cefoxitin (30 µg), 
P: penicillin (10 units), T: tetracycline (30 µg), TEC: teicoplanin (30 μg), DA: clindamycin (2 μg), CHL: 
chloramphenicol (30 μg), LZD: linezolid (30 μg), and RD: rifampin (5 μg). The isolates were categorized 
as susceptible, intermediate resistant, or resistant according to the recommendations of Clinical and 
Laboratory Standard Institute (CLSI) [14].  
2.4 mecA gene determination and SCCmec typing 
The mecA gene was determined for all isolates using PCR method as described previously [15]. SCCmec 
types were determined for all mecA positive isolates by evaluating the mec and ccr complexes [15].   
2.5 Multi locus sequence typing of S. epidermidis 
The mecA positive isolates (n=60) were analysed for seven housekeeping genes using multi locus 
sequence typing (MLST) as described previously [16]. In brief, seven house-keeping genes of each 
isolate were amplified by using arcC, aroE, gtr, mutS, pyr, tpi, and yqil primers and then sequenced by 
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Sangon Biotech (Shanghai, China). The sequence type for each isolate was assigned using the S. 
epidermidis MLST database (https://pubmlst.org/).  
2.6 Statistics 
The goeBURST algorithm (http://www.phyloviz.net/goeburst/) was used to build goeBURST diagram 
tree [11] . A hierarchy clustering heatmap was constructed using the MLST sequence type data, isolation 
source and SCCmec type and resistance profile of the mecA positive isolates using the r. package 
“Heatmap.plus” 
(https://www.rdocumentation.org/packages/heatmap.plus/versions/1.3/topics/heatmap.plus.package).Pr
incipal component analysis was performed to distinguish between antibiotic resistance profiles by site 
using the r packages “FactorMineR” (https://cran.r-project.org/web/packages/Facto MineR/index.html) 
and “factoextra” (https://cran.r-project.org/package =facto extra). 
The χ2 test was used to analyze the quantitative variables. A P-value < 0.05 was considered statistically 
significant. 
3. Results 
3.1 Study protocol and identification of isolates 
Samples were taken from hands of hospital personnel (n=68) and nasal cavity (n=39). 35 out of 68 (51%) 
hospital personnel were identified as carriers of S. epidermidis, including 24 of 68 (35%) carried S. 
epidermidis on their hands. 19 out of 39 (49%) hospital personnel were nasal carriers. In addition, 8 out 
of 68 (12%) carried S. epidermidis both on their hands and nasal cavity. A total of 165 isolates were 
recovered from the hands or nasal cavity samples of the hospital personnel working in two public 
hospitals in Tianjin city, China between March 2018 and May of 2018. 81 (81/165, 49%) isolates were 
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identified as S. epidermidis, including 40 isolates recovered from hands and 41 S. epidermidis isolated 
from nasal cavity.  
3.2 mecA gene determination of S. epidermidis 
The mecA gene was determined in 62 (62/81; 76.5%) isolates, including 30 (30/40; 75%) recovered from 
hospital personnel hands, and 32 (32/41; 78%) from nasal cavity. In addition, 33 (33/68; 49%) hospital 
personnel were carriers of MRSE, including 19 (19/68; 28%) carried MRSE on their hands and 19 (19/68; 
28%) carried MRSE in their nasal cavity. Moreover, 5 (5/68; 7%) of the hospital personnel were carriers 
of MRSE both on their hands and in the nasal cavities (Table 1).  
3.3 Antimicrobial susceptibility of MRSE 
The disc diffusion method was used to test the susceptibility of all S. epidermidis isolates (n=81) against 
10 antibiotics. Eighty-one (100%) isolates were resistant to at least one antibiotic. Resistance to penicillin 
and cefoxitin was observed in 70 out of 81 (86%) and 62 out of 81(77%) isolates respectively.  Thirty-
four (42%) isolates were resistant to erythromycin (R≦1.3 cm), whereas 18 (26%) isolates showed 
intermediate resistance (I=1.4-2.2 cm) towards erythromycin. Five (8%) isolates were resistant to 
gentamicin (R≦ 1.2 cm), and 4 (5%) to tetracycline (R≦1.4 cm).  (Table 1). Thirty-one (38%) isolates 
were resistant to teicoplanin (R≦ 1.0 cm), thirty-four (42%) isolates to clindamycin (R≦1.4 cm), six 
(7%) to chloramphenicol (R≦1.2 cm), six (7%) to linezolid (R≦ 2.0 cm), and thirteen (16%) to rifampin 
(R≦1.6 cm). All the mecA-negative S. epidermidis isolates were susceptible to cefoxitin. The majority 
of mecA-negative isolates were susceptible to gentamicin, chloramphenicol, linezolid and rifampin. 
Fourteen (14/19; 73.7%) mecA-negative isolates were resistant to penicillin, followed by 13 (13/19; 
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68.4%) to clindamycin, 12 (12/19; 63.2%) to erythromycin, and 6 (6/19; 31.6%) to teicoplanin (Table 
2).   
3.4 SCCmec typing of MRSE 
SCCmec types were determined for all 62 MRSE isolates. Thirty-seven (60%) isolates (from hands n=21; 
from nasal cavity n=16) harboured SCCmec type IV, followed by 15 (24%) SCCmec type V, and 4 (6%) 
SCCmec type II. In addition to this, 6 isolates were non-typeable, including 3 (5%) isolates harboured a 
combination of class C mec complex and the ccr type 3 complex, and 2 (3%) isolates carried class C mec 
complex and ccr type 2, whereas 1 (2%) isolate lacked mec complex but carried ccr type 3 complex 
(Table 1). 
3.5 Multi locus sequence typing of MRSE 
Multi locus sequence typing was performed to determine the sequence types of 60 MRSE, including 29 
recovered from hospital personnel hands (n=18) and 31 from nasal samples (n=18). The ST59 (n=19) 
was the most common sequence type, followed by ST35 (n=4), ST14 (n=3), ST57 (n=3), ST218 (n=3), 
ST20 (n=3), ST49 (n=2), ST69 (n=2), ST110 (n=2), ST152 (n=2), ST227 (n=2), ST466 (n=2), ST5 (n=1), 
ST6 (n=1), ST17(n=1), ST50 (n=1), ST84 (n=1), ST130 (n=1), ST190 (n=1), ST192 (n=1), and ST234 
(n=1). In addition, four isolates contained novel sequence types that were assigned as: ST832. ST833, 
ST834 and ST835. All 60 MRSE isolates were clustered into clonal complex 2 (CC2) by the goeBURST 
algorithm.  In addition, no singleton was detected (Fig 1).  
3.6 Hierarchical clustering Heatmap and PCA analysis 
A hierarchical cluster heatmap was performed on 60 MRSE isolates based on their site of isolation, 
SCCmec and MLST types (Fig 2A) to their antibiotic resistant profile. These analyses showed that there 
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was no obvious clustering based on the site of isolation, SCCmec and MLST types. This was further 
showed by PCA analysis on site isolates as the confidence ellipse overlapped each other (Fig 2B). 
3.7 Statistical analysis 
The χ2 test was used to analyse the quantitative variables. A P-value < 0.05 was considered statistically 
significant. 
4. Discussion 
S. epidermidis is a major nosocomial pathogen responsible for device associated infections [1]. Hospital 
personnel have an important role of being in direct contact with patients and subsequently play a key role 
in cross-transmission of MRSE [9]. In this study, we report the antimicrobial resistance patterns and 
genetic diversity of MRSE among the hospital personnel in Tianjin, China.  
The resistance of MRSE towards penicillin is well documented. Xin et al [11] reported that 90.4% of S. 
epidermidis isolates recovered from hospital environments were resistant to penicillin. Consistent with 
their results we have shown that 90% of MRSE isolates in our study were phenotypically resistant to 
penicillin. In addition, we have previously reported high levels of antibiotic resistance towards penicillin 
in environmental S. epidermidis (70%) isolates recovered from London [12]. Interestingly, in this study 
the resistance rates towards gentamicin (8%), and erythromycin (35%) were relatively low compared 
with others that demonstrated resistance towards gentamicin and erythromycin as 20% and 50% 
respectively [10,11]. Previously, it was shown that cefoxitin disk diffusion method was preferable for 
routine methicillin resistance screening of S. aureus, S. epidermidis and other CoNS isolates [17,18]. In 
this study, 62 (62/81, 77%) S. epidermidis isolates were resistant to cefoxitin, all of which carried the 
mecA gene. Li M et al, reported that resistance of clinical S. epidermidis isolates towards penicillin, 
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cefoxitin, gentamicin and erythromycin were 100%, 100%, 77.8% and 72.2% respectively [19]. In this 
study, the resistance towards non-β-lactam antibiotics in S. epidermidis isolates recovered from hospital 
personnel was significantly lower than that of clinical S. epidermidis isolates, whereas the resistance 
towards β-lactam antibiotics was similar to clinical S. epidermidis isolates. In this study, 100% S. 
epidermidis isolates were phenotypically resistant to at least 1 antibiotic. 22 out of 81 (27%) S. 
epidermidis isolates were resistant to 2 antibiotics, 27 isolates (33%) were resistant to 3 antibiotics, 18 
isolates (22%) were resistant to 4 antibiotics, 5 (6%) isolates were resistant to 5 antibiotics, 5 (6%)isolates 
were resistant to 6 antibiotics and 1 (1.2%) isolate was resistant to 9 antibiotics.  
In this study 32 (91%) out of 35 S. epidermidis carriers were identified to carry MRSE. Although, in this 
study the carriage of MRSE among the hospital personnel was significantly higher than among the 
hospital personnel in Shanghai, China [11], our findings were consistent with the MRSE rates (89%) 
among the hospital personnel in Intensive Care Unit in Sweden [10]. Previously, it was reported that the 
rate of MRSE carriage among the volunteers and in the environment was 11% [20], which was 
significantly lower than the rate of MRSE carriage among the hospital personnel.   
The size of SCCmec IV and V is smaller than those of SCCmec types I, II and III, and thus conferring 
SCCmec IV and V increased mobility and dissemination ability [21]. Li et al reported that 35% of clinical 
MRSE harboured SCCmec types IV and V in China [19]. In this study, 60% of MRSE harboured SCCmec 
type IV, followed by 24% harbouring SCCmec type V. We determined that 6% of MRSE that carried 
SCCmec type II were recovered from nasal samples. SCCmec II was reportedly identified in clinical S. 
aureus, S. epidermidis and other coagulase negative staphylococci [19]. Interestingly, we did not identify 
SCCmec types I, and III, which in contrast have been identified by Xin D. et al in isolates recovered from 
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hospital personnel in Shanghai [11]. Six previously un-classified SCCmec types were determined in this 
study, including 3 carrying class C mec complex and ccr 3, and 2 had a combination of class C mec 
complex and ccr 2. In addition, one MRSE was classified as SCCmec12263 since it lacked mec complex.  
For S. epidermidis, one major clonal complex (CC2), 8 minor clonal complexes and 13 singletons have 
been categorized [16]. In this study, all MLST types were classified into one major CC2 clonal complex, 
hence we did not detect isolates belonging to minor clonal complexes or singletons (Fig 1). However, 
although belonging to one CC group, in our study, we detected a diversity of MLST types (n=25). 
Miragaia et al summarized the sequence types of CC2 that accounted for 74% of the S. epidermidis 
population, and divided them into 2 clusters: cluster I: included the predicted ancestor (ST2) and cluster 
II: included several subgroup founders (ST5, -6, -57, -85, and -89) [16]. In this study, the majority of 
sequence types were categorized into cluster II, including those identified as subgroup founders: ST5, 
49, 57, 110, 152, and 835 (Fig 1). In addition, two isolates belonged to ST35. Miragaia et al reported that 
ST2 of cluster I is the most widely disseminated sequence type that has been identified in thirteen 
different countries [16]. In this study, no ST2 was determined among the S. epidermidis isolates 
recovered from two hospital personnel in Tianjin, China. However, the ST59 of cluster II was the most 
frequently identified sequence type. Isolates belonging to ST59 sequence type were reported to be only 
the second to the ST2, a prominent cause of clinical infections in China [11]. Thus, the prevalence of 
ST59 among the hospital personnel is rather worrying.  
Previously, whole genome sequencing studies revealed that environmental S. epidermidis ST59 isolate 
carried SCCmec type IV mobile genetic element [22]. To the best of our knowledge, this is the first study 
reporting that isolates belonging to ST59 harboured unclassified SCCmec types (C/2 and C/3) (Fig 1).  
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S. epidermidis ST5 has been associated with clinical and animal infections [23], whereas S. epidermidis 
ST6, ST20, ST110, ST130 and ST152 were associated with clinical infections [8,24,25]. It is largely 
known that the main transmission route of staphylococci is person to person and hospital personnel play 
a major role in such transmission [1]. Thus, our study provides further insights on the colonization of the 
hospital personnel with S. epidermidis. In addition, Xin et al reported a variety of S. epidermidis sequence 
types identified among hospital personnel (ST14, ST16, ST54, ST88, ST153, ST171, ST184, ST190, 
ST192, ST193, ST194, ST203, ST204, ST210, ST218, ST219, ST220, ST226, ST233, ST237, ST262, 
ST267, ST291, ST327, ST362, ST387, ST406, and ST466) [11]. Some of the sequence types (ST14, 
ST190, ST218, and ST466) identified in this study were consistent with their findings.  However, in 
addition to this we also report sequence types (ST35, ST57, ST69, ST84, ST227, and ST234) that were 
not identified by Xin et al. [11]. In addition, four new MLST types were determined in this study.  
We did not detect any obvious clustering based on site of isolation, SCCmec types and MLST types (Fig 
2A). This was further demonstrated by PCA analysis on site isolates as the confidence ellipse overlapped 
each other (Fig 2B). Other authors reported discrepancies between the antibiotic resistance profile and 
different types of SCCmec elements [26]. This report shows that SCCmec type III and IV in S. 
epidermidis were more likely to be resistant to a larger number of antibiotics. 
5. Conclusion 
The main limitation of this study is that only samples recovered from the hospital personnel were 
included. The carriage of MRSE (91%) was unusually high among hospital personnel who were carriers 
of S. epidermidis. We also observed different MRSE colonization rate in hospital personnel in two 
hospitals. The MRSE isolates had high resistance rates towards β-lactam antibiotics, but low resistance 
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rates against non-β-lactam antibiotics. Moreover, the majority of MRSE in this study belonged to cluster 
II domain of CC2. ST59-IV was the predominant clone among isolates recovered from hospital 
personnel, a sequence type that was reportedly associated with clinical infections. Moreover, new MLST 
types were determined, thus further confirming the genetic variability of these isolates. Our data 
demonstrate that the hospital personnel may well act as a reservoir of antimicrobial resistance pathogens. 
Undoubtably, there is a need to review the infection control strategies and implement appropriate 
screening and monitoring measures to identify the high carriage of MRSE among hospital personnel on 
timely manner. 
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Figure 1 goeBURST analysis of 60 MRSE isolates recovered from hospital personnel in China 
 
ST nodes: Dark green circles: sub-group founder; Light blue circles: common nodes  
Light green: SCCmec II; Dark yellow: SCCmec IV; Turquoise: SCCmec V; Red: SCCmec C/2; Blue: 
SCCmec C/3; Purple: non-typable SCCmec  
 
Figure 2 Hierarchy cluster heatmap and PCA analysis of MRSE isolates antibiotic resistance profile 
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(A) Hierarchy clustered heatmap. Red tile resistant, Black tile intermediate, green tile sensitive. (B) 
PCA analysis. 95% confidence ellips 
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Table 1 Antibiotic resistance and molecular characterization of mecA gene positive S. epidermidis 
ID Hospital Personnel Sites Species mecA mec ccr SCCmec FOX30 
Other antibiotics 
CHL30 CN10 DA2 E15 LZD30 P10 RD5 TEC30 T30 
1 A A1 H S.epidermidis  + B 2 IV R S S R S S R S I S 
2 A A12 H S.epidermidis + B 2 IV R R S I R S R S I S 
3 A A2 H S.epidermidis + B 2 IV R S S I I S R S R S 
4 A A3 H S.epidermidis + B 2 IV R S S S S S S S R S 
5 A A1 H S.epidermidis + B 2 IV R S S I S R R S I S 
6 A A1 H S.epidermidis + B 2 IV R S S S S S R R R I 
7 A A2 H S.epidermidis + B 2 IV R S S I S S R S R S 
8 A A4 H S.epidermidis + B 2 IV R S S S I R R S R S 
9 A A12 H S.epidermidis + B 2 IV R R S I R S R S I S 
10 A A13 H S.epidermidis + B 2 IV R S S I R S R S R S 
11 A A1 H S.epidermidis + B 2 IV R S S I S S R S R S 
12 B B2 H S.epidermidis + B 2 IV R R R R R R R R R S 
13 B B3 H S.epidermidis + B 2 IV R R R R I S R S R S 
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14 B B3 H S.epidermidis + B 2 IV R R I I S R R R R S 
15 B B4 H S.epidermidis + B 2 IV R S S I S S R S I S 
16* B B4 H S.epidermidis + B 2 IV R S S S S S R S I S 
17 B B8 H S.epidermidis + B 2 IV R S S I I R R S R I 
18 B B11 H S.epidermidis + B 2 IV R S S S R S R S I S 
19 B B9 H S.epidermidis + B 2 IV R S S S S S R S I S 
20 B B16 H S.epidermidis + B 2 IV R S S S I S R S I S 
21 B B18 H S.epidermidis + B 2 IV R S R S S S S S I S 
22 B B15 H S.epidermidis + C 5 V R S S I R S R S I S 
23 B B5 H S.epidermidis + C 5 V R S S S R S R S R I 
24 B B1 H S.epidermidis + C 5 V R S S I R S R S R S 
25 A A5 H S.epidermidis + C 5 V R S S S R S R R I I 
26 A A3 H S.epidermidis + C 5 V R R S R R S R S R S 
27 A A4 H S.epidermidis + C 5 V R S S R R S R R I S 
28 A A3 H S.epidermidis + C 5 V R S S R I S R S I S 
29 A A5 H S.epidermidis + C 2 C/2 R S I R R S R R I S Jo
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30 B B17 H S.epidermidis + C 2 C/2 R S S R S S R S I S 
31 A A11 NC S.epidermidis + A 2 II  R S S R R S R S I S 
32 A A11 NC S.epidermidis + A 2 II  R S S R R S R S I S 
33 B B19 NC S.epidermidis + A 2 II R S S I R S S S I S 
34 B B20 NC S.epidermidis + A 2 II R S S S R S R S R S 
35 A A8 NC S.epidermidis + B 2 IV R S S I S S R S R S 
36 A A8 NC S.epidermidis + B 2 IV R S S R R S R S R S 
37 A A12 NC S.epidermidis + B 2 IV R S S S R S R S R S 
38 A A10 NC S.epidermidis + B 2 IV R S S S I S R S I S 
39 B B6 NC S.epidermidis + B 2 IV R S R S S S R S I S 
40 B B7 NC S.epidermidis + B 2 IV R S S R S S R S R S 
41 A A6 NC S.epidermidis + B 2 IV R S S I S R R S I S 
42 A A6 NC S.epidermidis + B 2 IV R S S R I S R S I S 
43 A A10 NC S.epidermidis + B 2 IV R S S S I S R S R S 
44 B B17 NC S.epidermidis + B 2 IV R S S I S S R R I S 
45* B B16 NC S.epidermidis + B 2 IV R S S I S S R S I S Jo
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46 B B12 NC S.epidermidis + B 2 IV R S S R S S S S I S 
47 B B12 NC S.epidermidis + B 2 IV R S S R I S S S S S 
48 B B10 NC S.epidermidis + B 2 IV R S S R I S R R R S 
49 B B16 NC S.epidermidis + B 2 IV R S S I S S R S I S 
50 B B18 NC S.epidermidis + B 2 IV R S S I S S R S R S 
51 A A7 NC S.epidermidis + C 5 V R S S R I S R S I S 
52 A A7 NC S.epidermidis + C 5 V R S S I I S R R I S 
53 B B13 NC S.epidermidis + C 5 V R S S R R S R S R S 
54 B B13 NC S.epidermidis + C 5 V R S S R R S R R R S 
55 B B10 NC S.epidermidis + C 5 V R S S R R S R R I R 
56 B B10 NC S.epidermidis + C 5 V R S S I R S R R I S 
57 B B14 NC S.epidermidis + C 5 V R S S R I S R S I S 
58 B B18 NC S.epidermidis + C 5 V R S S I I S R S R S 
59 B B1 NC S.epidermidis + C 3 C/3 R S R I I S R S I R 
60 B B6 NC S.epidermidis + C 3 C/3 R S S I S S R S I S 
61 B B6 NC S.epidermidis + C 3 C/3 R S S S S S R S I S Jo
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62 A A9 NC S.epidermidis + NT 3 NT R S I I S S S S I S 
A: hospital 1, B: hospital 2; H: hand, NC: nasal cavity. NT: non-typeable, E: erythromycin; CN: gentamicin; FOX: cefoxitin; P: penicillin; T: tetracycline, TEC: teicoplanin, 
DA: clindamycin, CHL: chloramphenicol, LZD: linezolid, and RD: rifampin.NT non-typeable; * MLST type not determined. 
penicillin: (S≥2.9 cm, R≤2.8 cm), erythromycin(S≥2.3 cm, I=1.4-2.2 cm, R≤1.3 cm), cefoxitin (S≥2.5 cm, R≤2.4 cm), gentamicin (S≥1.5 cm, I=1.3-1.4 cm, R≤1.2 cm), 
tetracycline (S≥1.9 cm, I=1.5-1.8 cm, R≤1.4 cm ), teicoplanin (S≥1.4 cm, I=1.1-1.3 cm, R≦ 1.0 cm), clindamycin (S≥2.1 cm, I=15-20 cm, R≦1.4 cm), chloramphenicol 
(S≥1.8 cm, I=1.3-1.7 cm, R≦1.2 cm), linezolid (S≥2.1 cm, R≦ 2.0 cm), rifampin (S≥20 cm, I=1.7-1.9 cm, R≦1.6 cm) 
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Table 2 Antibiotic resistance of mecA gene negative S. epidermidis 
A: hospital 1, B: hospital 2; H: hand, N: nose. NT: non-typeable, E: erythromycin; CN: gentamicin; FOX: cefoxitin; P: penicillin; T: tetracycline, TEC: teicoplanin, DA: 
clindamycin, CHL: chloramphenicol, LZD: linezolid, and RD: rifampin. NT non-typeable; * MLST type not determined. 
ID Hospital Personnel Species mecA CHL30 CN10 DA2 E15 FOX30 LZD30 P10 RD5 TEC30 T30 
63 A A1 S.epidermidis – S S R I S S R S R S 
64 A A1 S.epidermidis – S S I R S S S S R S 
65 A A1 S.epidermidis – S S R R S S S S I S 
66 A A5 S.epidermidis – S S R S S S S S I S 
67 A A6 S.epidermidis – S S R R S S R S I S 
68 A A7 S.epidermidis – S S R I S S R S I R 
69 A A8 S.epidermidis – S S R R S S R S I S 
70 A A8 S.epidermidis – S S R R S S R S I S 
71 A A9 S.epidermidis – S S I R S S R R R S 
72 A A10 S.epidermidis – S S I S S S R S I S 
73 A A10 S.epidermidis – S S I S S S R S R S 
74 A A11 S.epidermidis – S S R R S S R S I S 
75 A A11 S.epidermidis – S S R S S S R S I S 
76 A A11 S.epidermidis – S S R R S S R S I S 
77 A A13 S.epidermidis – S S S R S S R S I S 
78 A A14 S.epidermidis – S S R S S S R S R R 
79 A A15 S.epidermidis – S S I R S S R S R S 
80 A A15 S.epidermidis – S S R R S S S S I S 
81 B B20 S.epidermidis – S I R R S S S S I I Jo
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penicillin: (S≥2.9 cm, R≤2.8 cm), erythromycin(S≥2.3 cm, I=1.4-2.2 cm, R≤1.4-2.2 cefoxitin (S≥2.5 cm, R≤2.4 cm), gentamicin (S≥1.5 cm, I=1.3-1.4 cm, R≤1.2 cm), 
tetracycline (S≥1.9 cm, I=1.5-1.8 cm, R≤1.4 cm ), teicoplanin (S≥1.4 cm, I=1.1-1.3 cm, R≦ 1.0 cm), clindamycin (S≥2.1 cm, I=15-20 cm, R≦1.4 cm), chloramphenicol 
(S≥1.8 cm, I=1.3-1.7 cm, R≦1.2 cm), linezolid (S≥2.1 cm, R≦ 2.0 cm), rifampin (S≥20 cm, I=1.7-1.9 cm, R≦1.6 cm) 
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